AMSTERDAM (AP) – The European Medicines Agency met on Thursday to discuss whether a single-dose coronavirus vaccine should be allowed, a move that would allow the EU to launch a fourth patented vaccine against a suspended vaccine. ,
The EU regulator based in Amsterdam is scheduled to convene its expert committee this morning to evaluate the data on J&J vaccines. The decision on whether the agency recommends shooting licenses in the 27-nation bloc could come in the afternoon.
EMA has already approved COVID-19 vaccines made by Pfizer-BioNTech, Moderna և AstraZeneca.
The US Food and Drug Administration approved the shooting of J&J in late February. Health experts hope that having a single dose of the vaccine will accelerate efforts to immunize the world against COVID-19, especially given the emergence of worrying new options in recent months.
The EU has struggled to shoot fast to vaccinate its most vulnerable citizens. It lags far behind countries such as Israel, Britain, Chile and the United States
Europe reported 1 million new COVID-19 cases last week, up 9% from the previous week, with a reversal of a six-week decline in new infections. The World Health Organization (WHO) blamed the increase in part on virus variants, including one first found in Britain, which is thought to be 50% more transmissible.
A massive study of three continents found that the J&J vaccine was 85% effective in protecting against serious illness, hospitalization and death. That protection has remained strong even in countries like South Africa, where versions have been found that appear to be less susceptible to other licensed vaccines, including those made by AstraZeneca.
J&J is also seeking emergency approval for its vaccine in the UK from the World Health Organization. The company hopes to reach about 1 billion doses this year. The vaccine has been approved for use in Bahrain and Canada.
– Follow AP epidemic coverage https://apnews.com/hub/coronavirus-pandemic, https://apnews.com/hub/coronavirus-vaccine և https://apnews.com/Und UndingingtheOutbreak